Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
CADASIL in central Italy: a retrospective clinical and genetic study in 229 patients.
[cadasil]
The
objective
of
the
study
is
to
detail
clinical
and
NOTCH
3
gene
mutational
spectrum
in
a
large
group
of
Italian
CADASIL
patients
.
Cerebral
autosomal
dominant
arteriopathy
with
subcortical
infarcts
and
leukoencephalopathy
(
CADASIL
)
is
a
familial
cerebral
small
vessels
disease
caused
by
mutations
in
the
NOTCH
3
gene
on
19
p
13
usually
presenting
in
young
or
middle
adulthood
.
Characteristic
features
include
migraine
,
recurrent
lacunar
stroke
,
subcortical
dementia
,
mood
disturbances
and
leukoencephalopathy
.
The
disorder
is
often
overlooked
and
misdiagnosed
.
CADASIL
prevalence
and
disease
burden
is
still
undetermined
.
We
retrospectively
reviewed
demographic
,
clinical
,
and
mutational
characteristic
of
all
CADASIL
patients
diagnosed
from
January
2002
to
December
2012
in
three
referral
centers
for
neurogenetic
and
cerebrovascular
diseases
in
central
Italy
.
229
NOTCH
3
positive
subjects
were
identified
.
Mean
age
at
diagnosis
was
57
.
8
Â
±
Â
14
.
7
Â
years
,
and
48
.
6
Â
±
Â
17
.
1
Â
years
at
first
symptom
onset
.
Most
frequent
clinical
symptoms
were
ischemic
events
(
59
Â
%
)
and
psychiatric
disturbances
(
48
Â
%
)
.
The
highest
percentage
of
mutations
were
found
on
exons
4
and
19
(
20
.
6
and
17
.
6
Â
%
respectively
)
,
the
remaining
being
dispersed
over
the
entire
EGF
-like
region
of
the
NOTCH
3
gene
.
209
patients
resided
in
a
circumscribed
geographic
area
which
included
three
regions
of
the
central
Italy
,
yielding
a
minimum
prevalence
of
4
.
1
per
100
.
000
adult
inhabitants
.
This
is
the
most
extensive
study
on
CADASIL
in
Italy
.
Clinical
phenotype
showed
several
peculiarities
in
frequency
and
presentation
of
the
main
disease
manifestations
.
Our
study
enlarges
the
number
of
pathogenic
NOTCH
3
mutations
and
due
to
the
heterogeneous
mutational
spectrum
observed
suggests
that
full
sequencing
of
exons
2
-
24
is
mandatory
for
CADASIL
screening
in
the
Italian
population
.